We are exploring a new treatment approach for patients with relapsed primary CNS lymphoma. This study aims to assess the safety of combining high-dose methotrexate with glucarpidase.
Health conditions and diseases that the clinical trial is designed to study and treat.
Primary Central Nervous System Lymphoma (PCNSL) is a rare type of cancer that occurs in the brain or spinal cord, characterized by the uncontrolled growth of lymphatic cells. It can lead to various neurological symptoms and requires specialized treatment.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.